THE EFFECTIVENESS OF RIVASTIGMINE IN REDUCING TARDIVE DYSKINESIA SYMPTOMS IN PATIENTS WITH SCHIZOPHRENIA

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

JAHANIAN AMIR ABBAS; REZAEI OMID; FADAEI FARBOD; YARAGHCHI AZADEH

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Iranian Journal of Psychiatry and Clinical Psychology Year:2014 | Volume:20 | Issue:1 (76) Page(s): 29-34

Download Full-Text

Persian Verion

View:

1,117

Download:

Cites:

Information Journal Paper

Title

THE EFFECTIVENESS OF RIVASTIGMINE IN REDUCING TARDIVE DYSKINESIA SYMPTOMS IN PATIENTS WITH SCHIZOPHRENIA

Author(s)

JAHANIAN AMIR ABBAS | REZAEI OMID | FADAEI FARBOD | YARAGHCHI AZADEH | Issue Writer Certificate

Keywords

TARDIVE DYSKINESIAQ2

RIVASTIGMINEQ2

SCHIZOPHRENIAQ3

ABNORMAL INVOLUNTARY MOVEMENT SCALEQ2

Abstract

Objectives: The aim of this study was to examine the effectiveness of RIVASTIGMINE on reducing TARDIVE DYSKINESIA (TD) symptoms in patients with SCHIZOPHRENIA receiving antipsychotic treatment.Method: Forty male patients with SCHIZOPHRENIA and TARDIVE DYSKINESIA symptoms [based on the Diagnostic and Statistical Manual of Mental Disorders, 4th. ed., Text Revision (DSM- IV-TR) criteria] hospitalized in Razi Psychiatric Hospital with a stable mental status within a month prior to the study were selected using convenience sampling. The subjects were randomly divided into two groups each with 20 individuals, one group received placebo and the other RIVASTIGMINE. At the beginning of the study and after eight weeks, severity of symptoms of TD was assessed by ABNORMAL INVOLUNTARY MOVEMENT SCALE (AIMS). Data analysis was done by analysis of covariance.Results: There were significant difference between posttest mean scores of the two groups (p<0.05).Conclusions: RIVASTIGMINE is effective in reducing TD symptoms in patients with SCHIZOPHRENIA.

Cites

No record.

References

No record.

Cite

APA: Copy

JAHANIAN, AMIR ABBAS, REZAEI, OMID, FADAEI, FARBOD, & YARAGHCHI, AZADEH. (2014). THE EFFECTIVENESS OF RIVASTIGMINE IN REDUCING TARDIVE DYSKINESIA SYMPTOMS IN PATIENTS WITH SCHIZOPHRENIA. IRANIAN JOURNAL OF PSYCHIATRY AND CLINICAL PSYCHOLOGY, 20(1 (76)), 29-34. SID. https://sid.ir/paper/16768/en

Vancouver: Copy

JAHANIAN AMIR ABBAS, REZAEI OMID, FADAEI FARBOD, YARAGHCHI AZADEH. THE EFFECTIVENESS OF RIVASTIGMINE IN REDUCING TARDIVE DYSKINESIA SYMPTOMS IN PATIENTS WITH SCHIZOPHRENIA. IRANIAN JOURNAL OF PSYCHIATRY AND CLINICAL PSYCHOLOGY[Internet]. 2014;20(1 (76)):29-34. Available from: https://sid.ir/paper/16768/en

IEEE: Copy

AMIR ABBAS JAHANIAN, OMID REZAEI, FARBOD FADAEI, and AZADEH YARAGHCHI, “THE EFFECTIVENESS OF RIVASTIGMINE IN REDUCING TARDIVE DYSKINESIA SYMPTOMS IN PATIENTS WITH SCHIZOPHRENIA,” IRANIAN JOURNAL OF PSYCHIATRY AND CLINICAL PSYCHOLOGY, vol. 20, no. 1 (76), pp. 29–34, 2014, [Online]. Available: https://sid.ir/paper/16768/en

Related Journal Papers